Keratinocyte Cytokine and Chemokine Receptors

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 467-476

  Tüzün, Yalçin ^a   Antonov, Meltem ^a   Dolar, Neslihan ^a   Wolf, Ronni ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR3; CYCLOSPORIN A; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 4; MACROPHAGE DERIVED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ATOPIC DERMATITIS; CELL POPULATION; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; ULCER;

CYTOKINES; HUMANS; KERATINOCYTES; RECEPTORS, CHEMOKINE; SKIN DISEASES; ULTRAVIOLET RAYS;

EID: 34548825389     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.003     Document Type: Review

References (21)

1. Williams I.R., Rich B.E., and Kupper T.S. Cytokines. In: Freedberg I.M., Ei{dotless}sen A.Z., Wolff K., et al. (Eds). Fitzpatrick's dermatology in general medicine. 6th edition (2004), Mc Graw Hill, New York 285-296
2. Homey B.M. Chemokines and inflammatory skin diseases. Adv Dermatol 21 (2005) 251-277
3. Giustizieri M.L., Mascia F., Frezzolini A., et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 107 (2001) 871-877
4. Witmann M., Purwar R., Hartman C., et al. Human keratinocytes respond to interleukin-18: implication for the course of chronic inflammatory skin diseases. J Invest Dermatol 124 (2005) 1225-1233
5. Schling P., Rudolph C., Heimerl S., et al. Expression of tumor necrosis factor alpha and its receptors during cellular differantion. Cytokine 33 (2006) 239-245
6. Lehmann B., Abraham S., and Meurer M. Role for tumor necrosis factor- α in UVB- induced conversion of 7 dehydrocholesterol to 1 α, 25-dihydroxivitamin D3 in cultured keratinocytes. J Steroid Biochem Mol Biol 90 (2004) 561-565
7. Lu K.Q., Brenneman S., Burns R., et al. Thalidomide inhibits UVB induced mouse keratinocyte apoptosis by both TNF α independent pathways. Photodermatol Photoimmunol Photomed 19 (2003) 272-280
8. Tsuru K., Horikawa T., Budiyanto A., et al. Low dose ultraviolet B radiation synergizes TNF-α to induce apoptosis of keratinocytes. J Dermatol Sci 26 (2001) 209-216
9. Cummins D., and Gaspari A. Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formation. Br J Dermatol 151 (2004) 458-464
10. Wei C.C., Chen W.Y., Wang Y.C., et al. Detection of IL20 and its receptors on psoriatic skin. Clin Immunol 17 (2005) 65-72
11. Otkjaer K., Kragballe K., Fundig A.T., et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 153 (2005) 911-918
12. Romer J., Hasselager E., Lisby P., et al. Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short term treatment with cyclosporine A or calcipotriol. J Invest Dermatol 121 (2003) 1306-1311
13. Wongpiyabovorn J., Suto H., Ushio H., et al. Up regulation of interleukin 13 receptor α1 on human keratinocytes in the skin of psoriasis and atopic dermatitis. J Dermatol Sci 33 (2003) 31-40
14. Xiao T., Kagami S., Saeki H., et al. Both IL-4 and IL-13 inhibit the TNF- α and IFN-λ enhance MDC production in a human keratinocyte cell line, HaCaT clls. J Dermatol Sci 31 (2003) 111-117
15. Wakugawa M., Nakamura K., Akatsuka M., et al. Expression oc CC chemokine receptor 3 on human keratinocytes in vivo and in vitro-upregulation by RANTES. J Dermatol Sci 25 (2001) 229-235
16. Ptering H., Kluthe C., Dulkys Y., et al. Characterization of the CC chemokine receptor 3 on human keratinocytes. J Invest Dermatol 116 (2001) 549-555
17. Yawalkar N., Uguccioni M., Scharer J., et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113 (1999) 43-48
18. Fukuoka M., Ogino Y., Sato H., et al. RANTES expression in psoriatic skin and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 138 (1998) 63-70
19. Galkowska H., Wojewodska U., and Olszewski W.L. Chemokines, cytokines and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen 14 (2006) 558-565
20. s and their receptors in chronic venous leg ulcers. J Invest Dermatol 117 (2001) 1282-1289
21. Jude E.B., Blakytny R., Bulmert J., et al. Transforming growth factor- beta 1,2,3 and receptor type I and II in diabetic foot ulcers. Diabet Med 19 (2002) 440-447